Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by mitch0frenchon Jun 14, 2017 10:05am
200 Views
Post# 26360765

RE:RE:RE:RE:PLI - FDA discussion

RE:RE:RE:RE:PLI - FDA discussion Dear Gonore,

you and i , can't predict what will happened in an organisation like the FDA with 16,000 employes and a reorganisation inside there wall ,with the new boss in place .
Maybe a good guy but probably not thinking like the predecessor ,if not ,why changing it. 
They are probably switching from chair to chair .
So , maybe ,everything in there wall is on the slow gear.

Do you know something doing better south of the border since the election


Bullboard Posts